Quantcast

Latest Sciele Pharma Inc. Stories

2009-09-14 06:00:00

SILVER SPRING, Md., Sept. 14 /PRNewswire/ -- The National Association of School Nurses (NASN) announced today the kickoff of S.C.R.A.T.C.H.

2009-08-05 10:00:00

Sciele Pharma, Inc., a Shionogi Company, today announced the availability of Ulesfia (Benzyl Alcohol Lotion 5%), the first and only prescription medication that kills head lice by asphyxiation without potential neurotoxic side effects. Approved by the U.S.

2008-11-07 09:00:05

Sciele Pharma, Inc.: -- Statistically and clinically significant increase in all three co-primary endpoints -- Well tolerated and devoid of systemic side effects Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Holdings PLC ("Plethora"-AIM:PLE), the specialist developer of products for the treatment and management of urological disorders, today announced that the European Phase III double-blind placebo-controlled study of PSD502 for the treatment of premature...

2008-10-23 09:00:10

Sciele Pharma, Inc., a Shionogi Company, today announced that Addrenex Pharmaceuticals, Inc. has initiated its Phase II clinical trial with ADX415 for the treatment of hypertension. This is a multicenter, double-blind, randomized, placebo-controlled, dose-ranging study that will involve 80 patients.

2008-10-09 18:00:12

On October 9, 2008, Shionogi & Co., Ltd. ("Shionogi") and Sciele Pharma, Inc. ("Sciele") (NASDAQ: SCRX) announced the completion of Shionogi's acquisition of Sciele for US$31.00 per share in cash.

2008-10-09 09:00:10

On October 9, 2008, Shionogi & Co., Ltd. ("Shionogi") and Sciele Pharma, Inc. ("Sciele") (NASDAQ: SCRX) announced the successful completion of the cash tender offer by Shionogi's indirect wholly owned subsidiary, Tall Bridge, Inc.

2008-10-06 06:00:36

On October 6, 2008, Shionogi & Co., Ltd. ("Shionogi") and Sciele Pharma, Inc. ("Sciele") (NASDAQ: SCRX) announced the successful completion of the tender offer by Shionogi's indirect wholly owned subsidiary, Tall Bridge, Inc.

2008-09-19 06:00:29

Shionogi & Co., Ltd. ("Shionogi") and Sciele Pharma, Inc.

2008-09-16 09:00:53

Sciele Pharma, Inc. (NASDAQ: SCRX) today announced the completion of a pivotal Phase III program to support an NDA filing for glycopyrrolate liquid.


Word of the Day
immane
  • Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.
The word 'immane' comes from the Latin word 'immanis', 'enormous'.
Related